Read More Healthcare Industry News Why OSE Immunotherapeutics stock is moving after Marc Le Bozec replaces Nicolas Poirier as CEO OSE Immunotherapeutics ousts CEO Nicolas Poirier, names Marc Le Bozec interim chief and launches a strategic review. See what it means for investors. byPallavi MadhirajuOctober 3, 2025